Avalon GloboCare Corp.

How big is Avalon GloboCare Corp.?

As of Jun 18, Avalon GloboCare Corp. has a market capitalization of 6.47 million, with net sales of 1.38 million and a net profit of -9.01 million over the latest four quarters. Shareholder's funds are reported at 7.10 million, and total assets amount to 20.99 million.

As of Jun 18, Avalon GloboCare Corp. has a market capitalization of 6.47 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 1.38 million, while the sum of net profit for the same period is -9.01 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at 7.10 million, and total assets amount to 20.99 million.

What does Avalon GloboCare Corp. do?

Avalon GloboCare Corp. is a biotech developer and healthcare service provider in the Pharmaceuticals & Biotechnology industry, currently reporting net sales of $0 million and a net loss of $2 million as of March 2025, with a market cap of $6.47 million.

Overview: <BR>Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider in the Pharmaceuticals & Biotechnology industry, operating within the micro-cap market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 6.47 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.76 <BR>Return on Equity: 237.63% <BR>Price to Book: -1.66<BR><BR>Contact Details: <BR>Address: 4400 US Highway 9 Ste 3100, FREEHOLD NJ : 07728-4210 <BR>Tel: 1 646 7624517 <BR>Fax: 1 732 7805600 <BR>Website: http://www.avalon-globocare.com/

Should I buy, sell or hold Avalon GloboCare Corp.?

Who are in the management team of Avalon GloboCare Corp.?

As of March 2022, Avalon GloboCare Corp.'s management team includes Mr. Lu Wenzhao (Chairman), Dr. David Jin (CEO), and Ms. Li Meng (COO). The Board of Directors also features independent directors such as Mr. Wilbert Tauzin and Mr. Steven Sanders.

As of March 2022, the management team of Avalon GloboCare Corp. includes the following individuals:<BR><BR>- Mr. Lu Wenzhao, Chairman of the Board of Directors<BR>- Dr. David Jin, President, Chief Executive Officer, and Director<BR>- Ms. Li Meng, Chief Operating Officer, Secretary, and Director<BR><BR>Additionally, the Board of Directors features several independent directors: Mr. Wilbert Tauzin, Mr. Steven Sanders, Mr. William Stilley, Dr. Tevi Troy, and Mr. Lu Yancen.

Is Avalon GloboCare Corp. overvalued or undervalued?

Avalon GloboCare Corp. is considered risky and overvalued due to negative financial metrics, including a Price to Book Value of -1.66, an EV to EBITDA ratio of -2.64, and a troubling ROCE of -180.71%, which positions it unfavorably compared to peers like CohBar, Inc. and Atreca, Inc.

As of 23 May 2017, Avalon GloboCare Corp. moved from a grade of does not qualify to risky. The company is overvalued given its negative financial metrics, including a Price to Book Value of -1.66 and an EV to EBITDA ratio of -2.64, indicating significant financial distress. Additionally, the Return on Capital Employed (ROCE) stands at a troubling -180.71%, further underscoring the company's challenges.<BR><BR>In comparison to its peers, Avalon GloboCare Corp. shows a less favorable position with a P/E ratio of -0.7611, while CohBar, Inc. holds a more attractive valuation with an EV to EBITDA of 0.8535. Atreca, Inc. is also in a precarious position with a P/E of -0.0467. Although specific return data is not available, the lack of positive performance metrics suggests that Avalon GloboCare Corp. is not keeping pace with broader market benchmarks like the S&P 500.

Is Avalon GloboCare Corp. technically bullish or bearish?

As of September 5, 2025, Avalon GloboCare Corp. is in a mildly bearish trend, with daily moving averages indicating bearishness, while weekly and monthly indicators show mixed signals.

As of 5 September 2025, the technical trend for Avalon GloboCare Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly and monthly MACD and KST show mildly bullish signals. Bollinger Bands are bearish on the weekly and mildly bearish on the monthly. The Dow Theory indicates a bearish trend on the monthly, with no trend on the weekly. There is no available return data to compare the company's performance against the S&P 500.